Comparison Chart CytomX Therapeutics, Inc.

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 14/05/2024 am IST			Pre-market 06:02:00 pm
1.89 ^USD	-4.55%		1.845	-2.38%

09/05	BMO Capital Adjusts Price Target on CytomX Therapeutics to $3.59 From $3.25, Maintains Market Perform Rating	MT
09/05	Wedbush Upgrades CytomX Therapeutics to Outperform From Neutral, Adjusts Price Target to $8 From $3	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	CYTOMX THERAPEUTICS, INC.	Bio Therapeutic Drugs	-4.55%	-56.75%	+21.94%	+6.18%	-82.50%	13Cr